Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer–tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2
Source abstract
Abstract
A new putty-like material with bone-inducing capacity was made by combining a block copolymer of poly d,l-lactic acid with randomly inserted p-dioxanone and polyethylene glycol (PLA-DX-PEG) and beta-tricalcium phosphate (beta-TCP) powder with added recombinant human bone morphogenetic protein-2 (rhBMP-2). To optimize the material's efficacy for bone formation, we formulated the optimal composition ratio of the respective constituent that gives the greatest osteoinductive efficacy in a mouse model of ectopic bone formation. In this series of studies, we investigated the size of ectopic bone mass induced 3 and 6 weeks after implantation of the materials composed of 30 mg of PLA-DX-PEG with 2 microg of rhBMP-2 and 0, 15, 30, or 60 mg of beta-TCP powder. An additional experiment was designed to investigate how content ratios of beta-TCP powder in 30 mg-putty implants (0%, 16.7%, 33.3%, 50%, 66.7%, 83.3%, or 100%) for a fixed dose (5 microg) of the rhBMP-2 altered the size of the induced ossicle. The results from the first experiment indicated that the bone yields were linearly dependent on the amount of additional beta-TCP powder. In the second experiment, the largest ossicles induced by 5 microg of rhBMP-2 were obtained when the polymer/beta-TCP ratio was 1/2 in mice. The data provide important insights into the fabrication of implants that provide efficacious delivery of rhBMP-2. The new putty-like material may be valuable for repairing or regenerating bone in a clinical setting.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone health and treatments · Bone Metabolism and Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. Novel regulators of bone formation: molecular clones and activities10.1126/science.3201241 ↗
2. Recombinant human bone morphogenetic protein induces bone formation10.1073/pnas.87.6.2220 ↗
3. Purification and characterization of a bone-inducing protein from a murine osteosarcoma (Dunn type)10.1097/00003086-199307000-00043 ↗
4. Gene cloning and expression of a bone morphogenetic protein derived from a murine osteosarcoma10.1097/00003086-199309000-00051 ↗
5. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients10.2106/00004623-200212000-00001 ↗
6. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 210.1097/01.BRS.0000048469.45035.B9 ↗
7. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect10.1302/0301-620X.81B4.0810710 ↗
8. Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies10.1097/00007632-200212010-00004 ↗
9. Uncertainty in xenotransplantation: individual benefit versus collective risk10.1038/nm0298-141 ↗
10. Last chance to stop and think on risks of xenotransplants
11. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives10.1097/00003086-199011000-00043 ↗
12. A biodegradable polymer as a cytokine delivery system for inducing bone formation10.1038/86715 ↗
13. New synthetic biodegradable polymers as BMP carriers for bone tissue engineering10.1016/S0142-9612(03)00040-1 ↗
14. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2)10.1016/j.biomaterials.2005.10.007 ↗
15. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model10.1097/01.brs.0000172155.17239.fa ↗
16. Biodegradable poly d,l-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone
17. New synthetic absorbable polymers as BMP carriers: plastic properties of poly d,l-lactic acid-polyethylene glycol block copolymers10.1002/(SICI)1097-4636(199910)47:1<104::AID-JBM15>3.0.CO;2-7 ↗
18. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier10.1016/S0142-9612(03)00041-3 ↗
19. Clinical evaluation of recombinant human bone morphogenetic protein-210.1097/00003086-200202000-00011 ↗
20. McKay B. Commercial approval of rhBMP-2 in spinal fusions: bringing the product to the market. In: Shandell LJ, Grodininsky AJ, editors. Tissue engineering in musculoskeletal clinical practice. USA: American Academy of Orthopaedic Surgeons; 2004. p. 61–71.
21. A new bone-inducing biodegradable porous beta-tricalcium phosphate10.1002/jbm.a.30102 ↗
22. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity10.1002/jbmr.5650101110 ↗
23. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts10.1016/S8756-3282(00)00358-6 ↗